Search for: "Teva Pharmaceuticals" Results 161 - 180 of 1,422
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Apr 2015, 1:28 pm
Supreme Court on Monday rejected Teva Pharmaceuticals USA Inc.'s request to review a Pennsylvania appellate ruling that federal law did not preempt the product liability claims of thousands of generic Reglan users. [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
20 Aug 2009, 1:06 pm by davidi
District Court Judge Garrett Brown rejected the argument made by Teva Pharmaceuticals Industries Ltd. that the patent covering the main ingredient in Merck & Co. [read post]
9 Jan 2016, 6:00 pm by Lawrence B. Ebert
Patent Docs began:In January, the Supreme Court held in Teva Pharmaceuticals USA, Inc. v. [read post]
1 Jul 2014, 10:00 pm by Courtenay C. Brinckerhoff
Teva Pharmaceuticals USA, Inc., the Federal Circuit affirmed the district court’s finding that BMS’s Baraclude® patent is invalid as obvious. [read post]
6 Aug 2006, 11:12 am
          by David Harper Abbott Laboratories and Teva Pharmaceuticals have settled their Biaxin XL patent infringement litigation in the U.S. [read post]
24 Feb 2009, 2:22 pm by Aaron Barkoff
  Specifically, Teva changed the particle size manufacturing specification of its active pharmaceutical ingredient and the method of measuring the particle size. [read post]
24 Apr 2016, 9:02 pm by Patent Docs
Teva Pharmaceuticals USA Inc. et al. v. [read post]
17 Jan 2016, 8:19 pm by Patent Docs
• Defendants: Teva Pharmaceuticals USA Inc.; Teva Pharmaceutical Industries Ltd. [read post]
17 Oct 2018, 7:49 pm by Brian Craig
The Federal Circuit found the district court committed no error in construing claim terms as non-limiting for nonobviousness purposes or in invalidating as obvious all asserted claims of the Copaxone patents, including a 40-milligram dosage three times per week (Teva Pharmaceuticals USA, Inc. v. [read post]
23 Jan 2022, 5:38 am by Kevin LaCroix
As reflected in their January 18, 2022 stipulation of settlement, the parties to the consolidated Teva Pharmaceutical Industries securities class action litigation have reached an agreement to settle the case for a payment of $420 million. [read post]
15 May 2023, 1:00 pm by Steve Brachmann
The Supreme Court also denied Teva Pharmaceuticals’ petition to review its appeal of the Federal Circuit’s “skinny label” induced infringement ruling over its generic version of carvedilol. [read post]
15 May 2023, 1:00 pm by Steve Brachmann
The Supreme Court also denied Teva Pharmaceuticals’ petition to review its appeal of the Federal Circuit’s “skinny label” induced infringement ruling over its generic version of carvedilol. [read post]
28 Jun 2009, 3:08 pm
• Defendants: Teva Parenteral Medicines, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
22 Jul 2014, 5:14 am by Lawrence B. Ebert
The Supreme Court has neither granted nor denied the Company's petition, but appears to be holding the petition pending its decision in Teva Pharmaceuticals USA, Inc. v. [read post]
14 Jul 2013, 9:23 pm by Patent Docs
• Defendants: Teva Pharmaceuticals USA Inc.; Teva Pharmaceutical Industries Ltd. [read post]
8 Sep 2017, 5:07 am by Lindsay Offutt
Filed in the First Judicial District Court for Santa Fe County [official website], the lawsuit claims that major opioid manufacturers, including Purdue Pharma, Johnson and Johnson, Endo Health Solutions, Teva Pharmaceutical Industries and Actavis [corporate websites], falsely represented and downplayed the highly addictive nature of the... [read post]
17 Oct 2007, 10:00 pm
I have just found out from the Generic Pharmaceuticals and IP blog that Teva has now sued 16 companies in relation to its Carvedilol process patents.The 16 defendants are: Zentiva; Mylan; Taro Pharmaceuticals; Lupin; Moehs Iberica; Urquima; Orchid; Wanbury;Z hejiang  Huahai; USV Ltd.; Cadila; Ranbaxy; Dr. [read post]
26 Oct 2009, 8:59 pm
District Court for the District of New Jersey denied Teva Pharmaceutical's bid to have Novartis Pharmaceuticals' patent infringement suit dismissed for lack of plaintiff standing. [read post]
26 Aug 2009, 9:59 pm
Plaintiff-Appellant Ortho-McNeil Pharmaceutical, Inc. owns the '221 patent, which relates to a tramadol and acetaminophen composition for use in prescription pain relief. [read post]